Lin (Lydia) Yang
CIK: 0002113703
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
UPC
Universe Pharmaceuticals INC
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Yang Lin (Lydia)
Yang Lin (Lydia) (SEC CIK 0002113703) files insider reports with the SEC as Chief Financial Officer of Universe Pharmaceuticals INC (UPC).
Signal8 holds 1 ownership filing by Yang Lin (Lydia), a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Yang Lin (Lydia)'s filings is in JI'AN, JIANGXI.
Other insiders filing for Universe Pharmaceuticals INC (UPC)
- Lai Gang, Chief Executive Officer
- Zheng Ding, Director
- Liu Baochang, Chief Operating Officer
- Pang Jiawen, Director
- Yu Yongping, Director